Factor in resectable non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 11, Issue 8, 2016, Pages 1311-1318

  Yotsukura, Masaya ^a   Ohtsuka, Takashi ^a   Kaseda, Kaoru ^a   Kamiyama, Ikuo ^a   Hayashi, Yuichiro ^b   Asamura, Hisao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Inflammation; Lung cancer; Prognostic factor; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; GLASGOW PROGNOSTIC SCORE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR INVASION; BLOOD; LUNG TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS;

C REACTIVE PROTEIN; SERUM ALBUMIN;

C-REACTIVE PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 84982182429     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2016.04.029     Document Type: Article

References (27)

1. Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003;21:3-7.
2. Forrest LM, McMillan DC, McArdle CS, et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable nonsmall-cell lung cancer. Br J Cancer. 2003;89:1028-1030.
3. Forrest LM, McMillan DC, McArdle CS, et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-smallcell lung cancer. Br J Cancer. 2004;90:1704-1706.
4. Leitch EF, Chakrabarti M, Crozier JE, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97:1266-1270.
5. Crozier JE, Leitch EF, McKee RF, et al. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg. 2009;197:544-549.
6. Crumley AB, Stuart RC, McKernan M, et al. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg. 2010;34: 2393-2398.
7. Pinato DJ, Shiner RJ, Seckl MJ, et al. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer. 2014;110:1930-1935.
8. Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104: 726-734.
9. Ikeda M, Natsugoe S, Ueno S, et al. Significant host-and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg. 2003;238:197-202.
10. Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin. 2008;58:180-190.
11. McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534-540.
12. McMillan DC, Crozier JE, Canna K, et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22:881-886.
13. Takeno S, Hashimoto T, Shibata R, et al. The highsensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Oncology. 2014;87:205-214.
14. Proctor MJ, Horgan PG, Talwar D, et al. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer. 2013;119:2325-2332.
15. Mohri Y, Tanaka K, Ohi M, et al. Prognostic significance of host-and tumor-related factors in patients with gastric cancer. World J Surg. 2010;34:285-290.
16. Woo Y, Hyung WJ, Obama K, et al. Elevated highsensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. J Surg Oncol. 2012;105:405-409.
17. Brown DJ, Milroy R, Preston T, et al. The relationship between an inflammation-based prognostic score (Glasgow prognostic score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol. 2007;60: 705-708.
18. Dutta S, Crumley AB, Fullarton GM, et al. Comparison of the prognostic value of tumour-and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg. 2011;35:1861-1866.
19. Dutta S, Crumley AB, Fullarton GM, et al. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Am J Surg. 2012;204: 294-299.
20. Tomita M, Ayabe T, Chosa E, et al. Prognostic significance of pre-and postoperative glasgow prognostic score for patients with non-small cell lung cancer. Anticancer Res. 2014;34:3137-3140.
21. Hirashima K, Watanabe M, Shigaki H, et al. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol. 2014;49:1040-1046.
22. Kinoshita T, Ito H, Miki C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer. 1999;85:2526-2531.
23. Ito H, Miki C. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol. 1999;34:1139-1143.
24. Nozoe T, Iguchi T, Adachi E, et al. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today. 2011;41:510-513.
25. Koike Y, Miki C, Okugawa Y, et al. Preoperative Creactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol. 2008;98:540-544.
26. Fujitsuka N, Asakawa A, Amitani H, et al. Efficacy of ghrelin in cancer cachexia: clinical trials and a novel treatment by rikkunshito. Crit Rev Oncog. 2012;17: 277-284.
27. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17: 432-437.